PEDIATRICS Vol. 83 No. 5 May 1989, pp. 737-741
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Forman, H. P.
Right arrow Articles by Feinstein, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forman, H. P.
Right arrow Articles by Feinstein, S.

Cerebral Vasculitis and Hemorrhage in an Adolescent Taking Diet Pills Containing Phenylpropanolamine: Case Report and Review of Literature

Howard P. Forman 1, Stanley Levin MD1, Barbara Stewart MD1, Mahendra Patel MD1, and Stuart Feinstein MD1

1 The Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York

Phenylpropanolamine is consumed by millions of persons annually and is sold in varying dosages and combinations for different ailments. Adolescents are an especially susceptible group influenced by its action as an anorexiant. During the past 6 years, several cases have been reported of patients in whom intracerebral hemorrhage developed, with and without concomitant angiographic evidence of vasculitis, after taking phenylpropanolamine. In this report, the 11th documented case of phenylpropanolamine-associated intracerebral hemorrhage with vasculitis is described. This is the first case in an adolescent following the ingestion of an overdose of diet-aid pills. Cases of intracerebral hemorrhage with vasculitis have also been described in users and abusers of amphetamine, methamphetamine, and ephedrine, all sympathomimetics with chemical structures similar to that of phenylpropanolamine. This report should alert pediatricians to the potential use by their patients of nonprescription medications containing phenylpropanolamine whenever unexplained acute cerebral symptoms are present.

Key Words: cerebral hemorrhage • vasculitis • phenylpropanolamine • diet aids • angiography

Submitted on March 3, 1988
Accepted on May 9, 1988




This article has been cited by other articles:


Home page
 StrokeHome page
C. Cantu, A. Arauz, L. M. Murillo-Bonilla, M. Lopez, and F. Barinagarrementeria
Stroke Associated With Sympathomimetics Contained in Over-the-Counter Cough and Cold Drugs
Stroke, July 1, 2003; 34(7): 1667 - 1672.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
W. N. Kernan, C. M. Viscoli, L. M. Brass, J. P. Broderick, T. Brott, E. Feldmann, L. B. Morgenstern, J. L. Wilterdink, and R. I. Horwitz
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
N. Engl. J. Med., December 21, 2000; 343(25): 1826 - 1832.
[Abstract] [Full Text] [PDF]